02.01.24
Bioiberica, a global ingredient supplier, has entered into two strategic partnerships to launch joint health formulations using its branded ingredients Collavant n2 and Mobilee.
Collavant n2 is a native undenatured type II collagen which is known for a distinctive mechanism of action and low efficacious dosage. Meanwhile, Mobilee is a hyaluronic acid matrix ingredient which contains polysaccharides and collagen, formulated to support joint and muscle health.
In Mexico, the company partnered with IFA Celtics to launch Hialoflex, a formula which contains 40 mg of Collavant n2 and 80 mg of Mobilee per dose, leveraging this blend in the country for the first time.
“As a trusted brand that serves many physicians, who are key stakeholders in the local market, it’s important for us to have confidence in the ingredients we choose for our finished products. Quality, science and safety always guide our decisions, and that’s exactly why we chose Bioiberica’s Collavant n2 and Mobilee solutions,” said Dr. Julio H. Morfin, medical director at IFA Celtics. “But we didn’t team up with the company for its ingredient offering alone. A renowned name in the joint health sector, with 20-plus years of experience in the field, our collaboration saw us benefit from the support of Bioiberica’s experienced marketing and technical teams, 360-degree view of the landscape and expert-led training sessions.”
Bioiberica also partnered with Faes Farma in Spain for a finished supplement called Vitanatur Multicollagen. This formula combines 40 mg of Collavant n2, along with eggshell membrane, which contains types I, V, and X collagen, hyaluronic acid, magnesium, and vitamins C, K2, and D3, for joint, bone, and skin health support.
“We’re experts in collagen. However, bringing a new product to market is never risk-free, especially in a fast-growing and competitive landscape, like the mobility arena,” said Marina Escudero Garcia, healthcare and consumer product manager at Faes Farma. “With Bioiberica’s support and understanding of the local market, we were able to develop and launch Vitanatur Multicollagen with speed, ease, and confidence.”
Collavant n2 will also be featured in other Spanish branded products, including Colnatur by Laboratorios Ordesa, and Articolageno Nativo Plus by Reig Jofre.
“We strongly believe that strategic alliances are the powerhouse of transformative progress in the human health industry – including the joint health and mobility space,” said Joan Bassa, human health director at Bioiberica. “We aim to empower the healthcare evolution by supporting our growing network of valued partners with research and insights to propel innovation. Our most recent alliances with IFA Celtics and FAES FARMA – two leading-edge companies in their respective markets – is just another example of how we’re championing collaboration to drive change in the category.”
Collavant n2 is a native undenatured type II collagen which is known for a distinctive mechanism of action and low efficacious dosage. Meanwhile, Mobilee is a hyaluronic acid matrix ingredient which contains polysaccharides and collagen, formulated to support joint and muscle health.
In Mexico, the company partnered with IFA Celtics to launch Hialoflex, a formula which contains 40 mg of Collavant n2 and 80 mg of Mobilee per dose, leveraging this blend in the country for the first time.
“As a trusted brand that serves many physicians, who are key stakeholders in the local market, it’s important for us to have confidence in the ingredients we choose for our finished products. Quality, science and safety always guide our decisions, and that’s exactly why we chose Bioiberica’s Collavant n2 and Mobilee solutions,” said Dr. Julio H. Morfin, medical director at IFA Celtics. “But we didn’t team up with the company for its ingredient offering alone. A renowned name in the joint health sector, with 20-plus years of experience in the field, our collaboration saw us benefit from the support of Bioiberica’s experienced marketing and technical teams, 360-degree view of the landscape and expert-led training sessions.”
Bioiberica also partnered with Faes Farma in Spain for a finished supplement called Vitanatur Multicollagen. This formula combines 40 mg of Collavant n2, along with eggshell membrane, which contains types I, V, and X collagen, hyaluronic acid, magnesium, and vitamins C, K2, and D3, for joint, bone, and skin health support.
“We’re experts in collagen. However, bringing a new product to market is never risk-free, especially in a fast-growing and competitive landscape, like the mobility arena,” said Marina Escudero Garcia, healthcare and consumer product manager at Faes Farma. “With Bioiberica’s support and understanding of the local market, we were able to develop and launch Vitanatur Multicollagen with speed, ease, and confidence.”
Collavant n2 will also be featured in other Spanish branded products, including Colnatur by Laboratorios Ordesa, and Articolageno Nativo Plus by Reig Jofre.
“We strongly believe that strategic alliances are the powerhouse of transformative progress in the human health industry – including the joint health and mobility space,” said Joan Bassa, human health director at Bioiberica. “We aim to empower the healthcare evolution by supporting our growing network of valued partners with research and insights to propel innovation. Our most recent alliances with IFA Celtics and FAES FARMA – two leading-edge companies in their respective markets – is just another example of how we’re championing collaboration to drive change in the category.”
